Revelation

Elevage Medical Technologies Continues Expansion of Investment Team and Board

Retrieved on: 
Tuesday, February 27, 2024

AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.

Key Points: 
  • hires –
    AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital , dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board.
  • Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.
  • Dr. Evan Melrose, CEO of Elevage Medical, said, "We are thrilled with these three key additions to the Elevage team.
  • Dr. Makower is also the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Retrieved on: 
Tuesday, February 13, 2024

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, as part of a limited number of accepted abstract authors, the company was invited to give an oral presentation of new preclinical data on the potential therapeutic benefit of Gemini for the prevention of acute kidney injury (AKI) at The 29th International Conference on Advances in Critical Care Nephrology taking place in San Diego from March 12-15, 2024.

Key Points: 
  • Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, as part of a limited number of accepted abstract authors, the company was invited to give an oral presentation of new preclinical data on the potential therapeutic benefit of Gemini for the prevention of acute kidney injury (AKI) at The 29th International Conference on Advances in Critical Care Nephrology taking place in San Diego from March 12-15, 2024.
  • Gemini is the Company’s proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD®), a toll-like receptor 4 agonist, in development as a prevention for AKI and hospital acquired infection.
  • Robin Marsden, Senior Vice President of Biology, Revelation Biosciences
    Tuesday, March 12, 2024 Oral Session 2 Translational Research from 5:30 p.m-7:30 p.m. Pacific Time
    “I am excited to have the opportunity to share our recent preclinical data for prevention of AKI in the well-established ischemia reperfusion model,” said Robin Marsden, Senior Vice President of Biology.
  • James Rolke, Chief Executive Officer of Revelation added, “The Revelation team looks forward to initiating multiple clinical studies this year as we advance Gemini as a new therapy for this currently unmet medical need.”

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

Retrieved on: 
Monday, February 5, 2024

The warrants have an exercise price of $4.53 per share, are exercisable upon issuance, and will expire five years following the date of issuance.

Key Points: 
  • The warrants have an exercise price of $4.53 per share, are exercisable upon issuance, and will expire five years following the date of issuance.
  • Roth Capital Partners acted as sole placement agent for the offering.
  • The gross proceeds to the Company from the offering are approximately $6.2 million, before deducting the placement agent’s fees and other offering expenses payable by Revelation.
  • 333-276232), as amended, that was declared effective by the U.S. Securities and Exchange Commission (“SEC”), on January 31, 2024.

Our ancient primate ancestors had an appetite for soft fruits – and their diet shaped human evolution

Retrieved on: 
Monday, February 5, 2024

Did these early primates display behaviours and diets similar to modern species, or did they have much humbler beginnings?

Key Points: 
  • Did these early primates display behaviours and diets similar to modern species, or did they have much humbler beginnings?
  • Research on early anthropoids has often suggested a diet high in soft fruits.

Tracking anthropoid evolution

  • Read more:
    Revelations from 17-million-year-old ape teeth could lead to new insights on early human evolution

    All of these primates (humans, apes, and monkeys) are collectively called anthropoids, and we all share a common anthropoid ancestor that lived around 40 million years ago.

  • Genetic and molecular studies, along with fossil evidence, indicate the period from 40 to 25 million years ago was a critical phase for the evolution and spread of anthropoid primates.

Fossils of our earliest ancestors

  • Between 35 and 29.2 million years ago (when the fossils used in this study were deposited), the Fayum sat on the lush northern coast of Africa.
  • Several of the anthropoid primates from the site may represent either the direct ancestors of all (or some) living anthropoids.
  • Because of this, the Fayum offers a fascinating glimpse into the behaviour and life of our early ancestors.

Dietary interpretations

  • Our new study examined dental wear and disease in fossilised teeth from five Fayum anthropoid primates: Aegyptopithecus, Parapithecus, Propliopithecus, Apidium and Catopithecus.
  • We focused on tooth chipping patterns and dental caries (also known as cavities), key indicators in fossils of dietary habits.
  • This is substantially lower than the frequency observed in most modern anthropoids, where chipping frequencies range from 4% to 40% of teeth.

Adaptation and evolution

  • This includes colour vision that likely evolved as a need for finding ripe fruit among the foliage.
  • This rapid evolution of diverse species from humble anthropoid beginnings was likely in response to new ecological opportunities opening up.
  • Our journey into the past to unravel the lives of our ancestors continues, with each fossil adding a new piece to the puzzle of early primate evolution.


Matthew Robert Borths receives funding from the United States National Science Foundation and the Institute for Museum and Library Services. Carolina Loch and Ian Towle do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering

Retrieved on: 
Thursday, February 1, 2024

The warrants will have an exercise price of $4.53 per share, are exercisable upon issuance, and will expire five years following the date of issuance.

Key Points: 
  • The warrants will have an exercise price of $4.53 per share, are exercisable upon issuance, and will expire five years following the date of issuance.
  • The closing of the offering is expected to occur on or about February 5, 2024, subject to the satisfaction of customary closing conditions.
  • Roth Capital Partners is acting as sole placement agent for the offering.
  • The gross proceeds to the Company from the offering are expected to be approximately $6.2 million, before deducting the placement agent’s fees and other offering expenses payable by Revelation.

New Heaven New Earth Church of Jesus Graduates Hundreds of Thousands of Theology Students and Offers Free Course to Those Seeking to Master Revelation

Retrieved on: 
Tuesday, January 9, 2024

Graduates who complete the rigorous program can master the Bible and Revelation within one year.

Key Points: 
  • Graduates who complete the rigorous program can master the Bible and Revelation within one year.
  • The teachings of New Heaven New Earth Church of Jesus have attracted hundreds of thousands of people seeking to clearly understand the Bible, including pastors, church leaders and everyday believers.
  • In November 2023, Shincheonji Church of Jesus hosted its third graduation of more than 100,000 theology students.
  • More information about New Heaven New Earth, Shincheonji Church of Jesus can also be provided via email.

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023

Retrieved on: 
Monday, November 13, 2023

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and nine months ended September 30, 2023 financial results.

Key Points: 
  • Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and nine months ended September 30, 2023 financial results.
  • Presented at the Healthcare Opportunities Conference hosted by ROTH MKM in October 2023.
  • Revelation’s net cash used for operating activities for the nine months ended September 30, 2023 was $5.3 million compared to net cash used for operating activities of $10.3 million for the same period in 2022.
  • Net income for the nine months ended September 30, 2023 was primarily due to the change in fair value of the warrant liability creating a $8.3 million gain.

Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

Retrieved on: 
Wednesday, November 29, 2023

SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer.

Key Points: 
  • SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer.
  • His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation.
  • As the firm's new Chief Financial Officer and Chief Operating Officer, Mr. Olson brings more than 17 years of experience in leadership roles in private and public companies.
  • He joins Revelation Partners from SVB Capital, where serving as Chief Financial Officer, he oversaw finance and operations for the company and its fund of funds, direct investment, and private credit strategies.

For the Third Time, New Heaven New Earth Church of Jesus Graduates More Than 100,000 Theology Students in One Year

Retrieved on: 
Sunday, November 19, 2023

A total of 108,084 theology students graduated from the church's Zion Christian Mission Center as part of Class 114.

Key Points: 
  • A total of 108,084 theology students graduated from the church's Zion Christian Mission Center as part of Class 114.
  • Sunday's graduation was not the first time Shincheonji Church managed to graduate over 100,000 students all at once.
  • Outside of South Korea, graduates from Class 114 include 35,792 graduates from other countries in Asia, 12,676 graduates from Africa, 2,927 graduates from Europe, 2,904 graduates from the Americas and 871 graduates from Oceania.
  • For more information about New Heaven New Earth Shincheonji Church of Jesus, please visit scjamericas.org or send an email to [email protected] .

The Nation of Malawi is Experiencing the Fruit of Repentance, Which Has Roots Dating to 2015 in reviveINDIANA

Retrieved on: 
Tuesday, November 14, 2023

He will be speaking on how Malawi is experiencing the fruit of repentance, the beginnings of which can be traced back to reviveINDIANA in 2015.

Key Points: 
  • He will be speaking on how Malawi is experiencing the fruit of repentance, the beginnings of which can be traced back to reviveINDIANA in 2015.
    reviveINDIANA kicked off in 2015 with a week of prayer that turned into 52 straight days of outreach in the Elkhart/Goshen area.
  • This led to working with established revived school leaders in Malawi and eventually an introduction to the president, Dr. Lazarus Chakwera.
  • This repentance is leading to fruit in the government, prisons, farms, education, police, and even the mining industry.
  • Brian Kamwendo, the Presidential Advisor on Religions Affairs for Malawi, on the effects of repentance on an entire nation.